Published in J Inherit Metab Dis on January 01, 1984
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis (2014) 1.73
Animal models of maple syrup urine disease. J Inherit Metab Dis (2009) 0.99
Clinical approach to inherited metabolic diseases in the neonatal period: a 20-year survey. J Inherit Metab Dis (1989) 0.83
Continuous venovenous haemodiafiltration in the acute phase of neonatal maple syrup urine disease. J Inherit Metab Dis (1997) 0.81
Methylmalonic acidemia mimicking diabetic ketoacidosis and septic shock in infants. Indian J Crit Care Med (2015) 0.81
Metabolic Effects of Increasing Doses of Nitisinone in the Treatment of Alkaptonuria. JIMD Rep (2015) 0.79
Maternal Diabetes Leads to Adaptation in Embryonic Amino Acid Metabolism during Early Pregnancy. PLoS One (2015) 0.75
A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics (1954) 3.69
Idiopathic hyperglycinemia and hyperglycinuria: a new disorder of amino acid metabolism. I. Pediatrics (1961) 3.10
Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. Arch Dis Child (1967) 2.56
The natural history of the inherited methylmalonic acidemias. N Engl J Med (1983) 2.12
Isovaleric acidemia: a new genetic defect of leucine metabolism. Proc Natl Acad Sci U S A (1966) 2.00
DIETARY TREATMENT OF A CHILD WITH MAPLE SYRUP URINE DISEASE (BRANCHED-CHAIN KETOACIDURIA). Arch Dis Child (1963) 1.87
Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J Clin Invest (1979) 1.73
Maple syrup disease; isolation and identification of organic acids in the urine. Pediatrics (1959) 1.54
Propionicacidemia, a new inborn error of metabolism. Pediatr Res (1968) 1.43
Maple syrup urine disease: branched-chain keto-aciduria. Pediatrics (1960) 1.42
The isolation and identification of N-isovalerylglycine from urine of patients with isovaleric acidemia. J Biol Chem (1967) 1.22
Outcome of early and long-term management of classical maple syrup urine disease. Pediatrics (1981) 1.22
Outcome of maple syrup urine disease. Arch Dis Child (1982) 1.20
MAPLE SYRUP URINE DISEASE, WITH PARTICULAR REFERENCE TO DIETOTHERAPY. Pediatrics (1964) 1.19
Isolation and identification of methylcitrate, a major metabolic product of propionate in patients with propionic acidemia. J Biol Chem (1972) 1.07
The specificity of glycine-N-acylase and acylglycine excretion in the organicacidaemias. Biochem Med (1974) 1.06
Hyperglycinemia and propionyl coA carboxylase deficiency and episodic severe illness without consistent ketosis. J Pediatr (1975) 0.99
L-carnitine therapy in propionicacidaemia. Lancet (1982) 0.98
Isovaleric acidemia: use of glycine therapy in neonates. N Engl J Med (1978) 0.97
Glycine therapy in isovaleric acidemia. J Pediatr (1978) 0.96
3-hydroxypropionate: significance of -oxidation of propionate in patients with propionic acidemia and methylmalonic acidemia. Proc Natl Acad Sci U S A (1972) 0.96
Propionic acidemia: a clinical update. J Pediatr (1981) 0.94
Correlation between blood ammonia concentration and organic acid accumulation in isovaleric and propionic acidemia. Pediatrics (1982) 0.94
Peritoneal dialysis in maple syrup urine disease. Lancet (1969) 0.94
Abnormal metabolites of isoleucine in a patient with propionyl-CoA carboxylase deficiency. Biomed Mass Spectrom (1978) 0.89
Reduction of plasma propionate by peritoneal dialysis. Pediatrics (1974) 0.88
[Isovaleric acidemia. Study and treatment in 3 brothers]. Arch Fr Pediatr (1976) 0.86
Therapeutic effects of glycine in isovaleric acidemia. Pediatr Res (1976) 0.86
Correlation between serum propionate and blood ammonia concentrations in propionic acidemia. J Pediatr (1978) 0.82
Isovaleric acidemia: results of family study and dietary treatment. Pediatrics (1973) 0.82
Dietary treatment and biochemical studies on a neonatal case of propionyl-CoA carboxylase deficiency. J Inherit Metab Dis (1982) 0.81
Occurrence of hyperammonemia in the course of 17 cases of methylmalonic acidemia. J Pediatr (1981) 0.80
Urea nitrogen excretion in critically ill children. Pediatrics (1982) 0.80
[Emergency treatment of an acute form of leucinosis by peritoneal dialysis]. Arch Fr Pediatr (1969) 0.80
Carnitine deficiency in premature infants receiving total parenteral nutrition: effect of L-carnitine supplementation. J Pediatr (1983) 0.79
The therapy of maple syrup urine disease. Am J Dis Child (1967) 0.78
Peritoneal dialysis update. J Pediatr (1982) 0.77
Maple syrup urine disease--therapeutic use of insulin in catabolic states. Eur J Pediatr (1982) 0.77
[Methyl malonic acidemia with hyperuricemic nephropathy]. Arch Fr Pediatr (1975) 0.77
[Neonatal leucinosis with favourable course. Therapeutic problems]. Ann Pediatr (Paris) (1977) 0.75
[Emergency treatment of inborn amino errors of amino acid metabolism detected in the neonatal period]. Arch Fr Pediatr (1979) 0.75
Exchange transfusion in acute episodes of maple syrup urine disease. Studies on branched-chain amino and keto acids. Eur J Pediatr (1982) 0.75
Methylmalonic acidemia: 6 years' clinical experience with two variants unresponsive to vitamin B12 therapy. Can Med Assoc J (1979) 0.75
Treatment of a neonate with propionic acidaemia and severe hyperammonaemia by peritoneal dialysis. Arch Dis Child (1979) 0.75
Management of maple syrup urine disease in Canada. Committee for improvement of Hereditary Disease Management. Can Med Assoc J (1976) 0.75
Isovalericacidemia: a case report. Pediatrics (1978) 0.75
Infection in maple-syrup-urine disease. Lancet (1971) 0.75
Maple syrup urine disease: treatment of the acutely ill newborn. Eur J Pediatr (1978) 0.75
[Prognosis of congenital methylmalonic aciduria. Correlations between tolerance to proteins, response to vitamin B12 and enzymatic defect (author's transl)]. Arch Fr Pediatr (1980) 0.75
Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids. Eur J Pediatr (1980) 0.75
[Endogenous renal clearance of amino acids: variations in relation to age]. Arch Fr Pediatr (1973) 0.75
Multiple exchange transfusions as treatment during the acute period in maple syrup urine disease. Helv Paediatr Acta (1972) 0.75
[Propionicacidemia. A report on two cases (author's transl)]. Ann Pediatr (Paris) (1979) 0.75
[Heterogeneity of leucinosis. Correlations between clinical manifestations, protein tolerance and enzyme deficiency]. Arch Fr Pediatr (1982) 0.75
[Value of peritoneal dialysis in the emergency treatment of metabolic diseases of constitutional origin revealed in the neonatal period]. Ann Med Interne (Paris) (1971) 0.75
[Acute leucinosis, normal psychomotor development at one year of age]. Ann Med Interne (Paris) (1971) 0.75
Organic acidaemia and Hyperammonaemia: review. J Inherit Metab Dis (1981) 0.75
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Conservation of the Caenorhabditis elegans timing gene clk-1 from yeast to human: a gene required for ubiquinone biosynthesis with potential implications for aging. Mamm Genome (1999) 9.96
Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet (1997) 6.08
Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med (1998) 5.22
A polymorphic DNA marker linked to cystic fibrosis is located on chromosome 7. Nature (1985) 5.07
Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta (1994) 4.93
Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet (2006) 4.64
Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet (1997) 4.26
Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet (2007) 4.13
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature (1994) 4.04
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature (2000) 3.61
Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosis. Nat Genet (1996) 3.51
Sucrose-negative variants of Candida tropicalis. J Clin Microbiol (1977) 3.48
Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet (1997) 3.37
Clinical features of 52 neonates with hyperinsulinism. N Engl J Med (1999) 3.35
Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.33
The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child (1979) 3.16
Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators. Lancet (1990) 3.12
Response of aequorin bioluminescence to rapid changes in calcium concentration. Nature (1969) 3.10
Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet (1995) 3.09
Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet (1989) 2.98
Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia (2009) 2.77
Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed (2000) 2.70
Mutant WD-repeat protein in triple-A syndrome. Nat Genet (2000) 2.54
Leber congenital amaurosis. Mol Genet Metab (1999) 2.52
Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc Natl Acad Sci U S A (1988) 2.47
Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest (1990) 2.46
19q13.11 deletion syndrome: a novel clinically recognisable genetic condition identified by array comparative genomic hybridisation. J Med Genet (2009) 2.37
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet (1998) 2.30
Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest (1995) 2.29
Clinical and genetic heterogeneity in retinitis pigmentosa. Hum Genet (1990) 2.26
In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet (2003) 2.26
A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet (1995) 2.24
Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet (2005) 2.24
Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology (1985) 2.23
Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med (1997) 2.23
Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest (1995) 2.22
Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J Virol (1995) 2.19
Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet (1999) 2.18
A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J (1999) 2.15
Structure and organization of the human survival motor neurone (SMN) gene. Genomics (1996) 2.12
The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol (1998) 2.04
Comment on antigen-reduced infant formulae. ESPGAN Committee on Nutrition. Acta Paediatr (1993) 2.04
Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet (1996) 2.01
Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis. J Med Genet (2005) 2.00
Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. Hum Mol Genet (2001) 2.00
A gene for hereditary multiple exostoses maps to chromosome 19p. Hum Mol Genet (1994) 2.00
Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet (2000) 2.00
Spectrum of ABCR gene mutations in autosomal recessive macular dystrophies. Eur J Hum Genet (1998) 1.97
X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet (1994) 1.97
Denaturing high-performance liquid chromatography (DHPLC)-based prenatal diagnosis for tuberous sclerosis. Prenat Diagn (2001) 1.95
Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest (1996) 1.91
[Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study]. Ann Fr Anesth Reanim (1994) 1.90
Radiation-reduction strategies in cardiac computed tomographic angiography. Clin Radiol (2010) 1.88
A gene for Usher syndrome type I (USH1A) maps to chromosome 14q. Genomics (1992) 1.85
Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol (1996) 1.84
Physiological and DNA characterization of Candida maltosa, a hydrocarbon-utilizing yeast. Arch Microbiol (1975) 1.83
Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene (1989) 1.83
Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol (2007) 1.82
FGFR2 mutations in Pfeiffer syndrome. Nat Genet (1995) 1.82
The patient-physician relationship. Teaching the human dimensions of care in clinical settings. JAMA (2001) 1.81
Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet (2005) 1.80
The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol (1991) 1.80
A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet (1993) 1.79
A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet (1998) 1.78
Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist's role. Histopathology (1998) 1.78
Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med (2001) 1.78
Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC) J Clin Invest (2000) 1.72
Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet (1998) 1.72
CpG dinucleotides are mutation hot spots in phenylketonuria. Genomics (1989) 1.70
Mutation analysis in Canadian families with choroideremia. Ophthalmic Genet (1996) 1.69
Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet (2000) 1.68
CHARGE syndrome: report of 47 cases and review. Am J Med Genet (1998) 1.68
Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet (1995) 1.68
Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from healthy sheep in Spain. J Clin Microbiol (2003) 1.67
Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases. J Inherit Metab Dis (2012) 1.66
Clinical and molecular heterogeneity of phenylalanine hydroxylase deficiencies in France. Am J Hum Genet (1988) 1.66
7q11.23 deletions in Williams syndrome arise as a consequence of unequal meiotic crossover. Am J Hum Genet (1996) 1.64
Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest (1997) 1.64
The retrospective diagnosis of a second outbreak of equine morbillivirus infection. Aust Vet J (1996) 1.64
A mutation in the human heme A:farnesyltransferase gene (COX10 ) causes cytochrome c oxidase deficiency. Hum Mol Genet (2000) 1.62
Genitopatellar syndrome: a new condition comprising absent patellae, scrotal hypoplasia, renal anomalies, facial dysmorphism, and mental retardation. J Med Genet (2000) 1.62
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q. Nat Genet (1993) 1.60
A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet (1988) 1.59
Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation (2001) 1.59
Parenteral with enteral nutrition in the critically ill. Intensive Care Med (2000) 1.59
Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet (1995) 1.59
Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest (1998) 1.58